The particularly favorable impact in diffuse large B-cell lymphoma (DLBCL) may reflect STAT5B’s role in preserving B-cell differentiation programs or counteracting oncogenic pathways. This evidence concerns the gene STAT5B and diffuse large B-cell lymphoma.